Genome Biologics

About:

Genome Biologics identifies novel tissue-specific RNAi therapies targeting the transcriptome of cardiovascular and cardiometabolic disease

Website: http://genomebiologics.com

Twitter/X: genomebiologics

Top Investors: European Innovation Council, EASME - EU Executive Agency for SMEs

Description:

Genome Biologics are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses where no other treatments have proven effective or ever existed.